Your browser doesn't support javascript.
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems.
Gassner, Christoph; Castilho, Lilian; Chen, Qing; Clausen, Frederik Banch; Denomme, Gregory A; Flegel, Willy A; Gleadall, Nick; Hellberg, Åsa; Ji, Yanli; Keller, Margaret A; Lane, William J; Ligthart, Peter; Lomas-Francis, Christine; Nogues, Nuria; Olsson, Martin L; Peyrard, Thierry; Storry, Jill R; Tani, Yoshihiko; Thornton, Nicole; van der Schoot, Ellen; Veldhuisen, Barbera; Wagner, Franz; Weinstock, Christof; Wendel, Silvano; Westhoff, Connie; Yahalom, Vered; Hyland, Catherine A.
  • Gassner C; Institute of Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein.
  • Castilho L; University of Campinas/Hemocentro, Campinas, Brazil.
  • Chen Q; Jiangsu Province Blood Center, Nanjing, Jiangsu, China.
  • Clausen FB; Department of Clinical Immunology, Laboratory of Blood Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
  • Denomme GA; Grifols Laboratory Solutions, San Marcos, Texas, USA.
  • Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Gleadall N; Department of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.
  • Hellberg Å; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.
  • Ji Y; Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China.
  • Keller MA; American Red Cross Blood Services, Philadelphia, Pennsylvania, USA.
  • Lane WJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Ligthart P; Department of Diagnostic Immunohematology, Sanquin, Amsterdam, The Netherlands.
  • Lomas-Francis C; Laboratory of Immunohematology and Genomics, New York Blood Center Enterprise, New York, New York, USA.
  • Nogues N; Banc de Sang i Teixits, Barcelona, Spain.
  • Olsson ML; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.
  • Peyrard T; Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.
  • Storry JR; Etablissement Français du Sang Ile-de-France, Centre National de Référence pour les Groupes sanguins, Ivry-sur-Seine, France.
  • Tani Y; UMR_S1134 Inserm Université Paris Cité, Paris, France.
  • Thornton N; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.
  • van der Schoot E; Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.
  • Veldhuisen B; Osaka Red Cross Blood Center, Osaka, Japan.
  • Wagner F; International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK.
  • Weinstock C; Department of Experimental Immunohematology, Sanquin, Amsterdam, The Netherlands.
  • Wendel S; Department of Diagnostic Immunohematology, Sanquin, Amsterdam, The Netherlands.
  • Westhoff C; Department of Experimental Immunohematology, Sanquin, Amsterdam, The Netherlands.
  • Yahalom V; German Red Cross Blood Service NSTOB, Springe, Germany.
  • Hyland CA; MVZ Clementinenkrankenhaus, Springe, Germany.
Vox Sang ; 117(11): 1332-1344, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2118457
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Under the ISBT, the Working Party (WP) for Red Cell Immunogenetics and Blood Group Terminology is charged with ratifying blood group systems, antigens and alleles. This report presents the outcomes from four WP business meetings, one located in Basel in 2019 and three held as virtual meetings during the COVID-19 pandemic in 2020 and 2021. MATERIALS AND

METHODS:

As in previous meetings, matters pertaining to blood group antigen nomenclature were discussed. New blood group systems and antigens were approved and named according to the serologic, genetic, biochemical and cell biological evidence presented.

RESULTS:

Seven new blood group systems, KANNO (defined numerically as ISBT 037), SID (038), CTL2 (039), PEL (040), MAM (041), EMM (042) and ABCC1 (043) were ratified. Two (039 and 043) were de novo discoveries, and the remainder comprised reported antigens where the causal genes were previously unknown. A further 15 blood group antigens were added to the existing blood group systems MNS (002), RH (004), LU (005), DI (010), SC (013), GE (020), KN (022), JMH (026) and RHAG (030).

CONCLUSION:

The ISBT now recognizes 378 antigens, of which 345 are clustered within 43 blood group systems while 33 still have an unknown genetic basis. The ongoing discovery of new blood group systems and antigens underscores the diverse and complex biology of the red cell membrane. The WP continues to update the blood group antigen tables and the allele nomenclature tables. These can be found on the ISBT website (http//www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/).
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Group Antigens / Erythrocytes / COVID-19 Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Vox Sang Year: 2022 Document Type: Article Affiliation country: Vox.13361

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Group Antigens / Erythrocytes / COVID-19 Type of study: Randomized controlled trials Limits: Humans Language: English Journal: Vox Sang Year: 2022 Document Type: Article Affiliation country: Vox.13361